Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
The invention provides particles, compositions including the particles, and methods of making the particles using electrospray. In certain embodiments, the particles allow for high concentrations of a therapeutic or diagnostic agent to be delivered at low viscosity. Particles may also exhibit beneficial properties with respect to stability.
1. A composition comprising particles comprising (a) a protein and (b) a carbohydrate, a salt, or a combination thereof, wherein at least a portion of the carbohydrate, salt, or combination thereof is localized at the particle surface and, wherein the protein in the particles has 0.5 to 1.0 activity per unit.
2. The composition of claim 1 , wherein the particles are in a suspension in a non-aqueous or aqueous liquid.
3. The composition of claim 2 , wherein the suspension has a viscosity from 0.27 to 200 cP.
4. The composition of claim 2 , wherein the suspension comprises from 5 to 90% particles by volume.
5. The composition of claim 1 , wherein the particles comprise the protein at a concentration from 0.0001 to 1000 mg/ml.
6. The composition of claim 2 , wherein the particles are in suspension in the non-aqueous liquid, which is an organic solvent or an ionic liquid.
7. The composition of claim 2 , wherein the particles are in suspension in the aqueous liquid, which is selected from the group consisting of water, 0.9% saline, lactated Ringer's solution, dextrose 5%, and a buffer.
8. The composition of claim 6 , wherein the non-aqueous liquid is the organic solvent, which is selected from the group consisting of benzyl alcohol, benzyl benzoate, castor oil, coconut oil, corn oil, cottonseed oil, fish oil, grape seed oil, hazelnut oil, hydrogenated palm seed oil, olive oil, peanut oil, peppermint oil, safflower oil, sesame oil, soybean oil, sunflower oil, vegetable oil, walnut oil, polyethylene glycol, glycofurol, acetone, diglyme, dimethylacetamide, dimethyl isosorbide, dimethyl sulfoxide, ethanol, ethyl acetate, ethyl ether, ethyl lactate, isopropyl acetate, methyl acetate, methyl isobutyl ketone, methyl tert-butyl ether, N-methyl pyrrolidone, perfluorodecalin, 2-pyrrolidone, trigylcerides, tetrahydrofurfuryl alcohol, triglycerides of the fractionated plant fatty acids C8 and C10, propylene glycol diesters of saturated plant fatty acids C8 and C10, ethyl oleate, ethyl caprate, dibutyl adipate, fatty acid esters, hexanoic acid, octanoic acid, triacetin, diethyl glycol monoether, gamma-butyrolactone, eugenol, clove bud oil, citral, limonene, and any combination thereof.
9. The composition of claim 6 , wherein the non-aqueous liquid is the organic solvent, which is selected from the group consisting of ethyl oleate and fatty acid esters.
10. The composition of claim 6 , wherein the non-aqueous liquid is the ionic liquid, which comprises pyridinium, pyridazinium, pyrimidinium, pyrazinium, imidazolium, pyrazolium, thiazolium, oxazolium, triazolium, ammonium, sulfonium, halides, sulfates, sulfonates, carbonates, phosphates, bicarbonates, nitrates, acetates, PF6-, BF4-, triflate, nonaflate, bis(trifyl)amide, trifluoroacetate, heptafluorobutanoate, haloaluminate, or any combination thereof.
11. The composition of claim 1 , wherein the particles have diameters from 0.1 to 1000 μm.
12. The composition of claim 1 , wherein the particles have a polydispersity index from 0.05 to 0.9.
13. The composition of claim 1 , wherein the carbohydrate is present and is dextran, trehalose, sucrose, agarose, mannitol, lactose, sorbitol, or maltose.
14. The composition of claim 1 , wherein the salt is present and is sodium chloride, calcium chloride, potassium chloride, sodium hydroxide, stannous chloride, magnesium sulfate, sodium glucoheptonate, sodium pertechnetate, or guanidine hydrochloride.
15. The composition of claim 1 , wherein the protein is an antibody.
16. The composition of claim 15 , wherein the antibody is human lgG or a monoclonal antibody.
17. The composition of claim 1 , wherein the protein is bovine serum albumin.
18. A method of administering a first therapeutic or diagnostic agent to a mammal, the method comprising administering an effective amount of a suspension or a dry formulation comprising particles to the mammal, wherein the suspension comprises a non-aqueous or aqueous liquid and the particles comprising (a) a protein and (b) a carbohydrate, a salt, or a combination thereof, wherein at least a portion of the carbohydrate, salt, or combination thereof is localized at the particle surface and, wherein the protein in the particles has 0.5 to 1.0 activity per unit.